This article is more than 5 years old. Information may no longer be current.

Alcon acquires Tear Film Innovations

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Tear Film Innovations, the manufacturer of the iLux device, has been acquired by Alcon, according to a press release.

The iLux device is used by eye care professionals to treat meibomian gland dysfunction. It uses disposable silicone pads to warm the eyelids to address blocked meibomian glands through the application of light-based heating, the release said.

“With the acquisition of Tear Film, we’re excited to bring this latest innovation to treat the millions of people around the world who suffer from dry eye,” Andy Pawson, Alcon president and general manager, global vision care franchise, said in the release. “Alcon remains committed to improving the lives of patients around the world through innovative technologies like the iLux device to address significant unmet needs in eye care.”

The FDA granted the iLux 510(k) clearance in December 2017. It is available in the United States and Canada, with an expansion to other countries planned for 2019.

Financial terms of the deal were not released.